LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 21 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,070 | -30.7% | 8,286 | -8.5% | 0.00% | – |
| Q2 2023 | $66,493 | +3040.9% | 9,059 | +1615.7% | 0.00% | – |
| Q1 2023 | $2,117 | -33.1% | 528 | -45.6% | 0.00% | – |
| Q4 2022 | $3,165 | – | 971 | +1417.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 64 | -95.5% | 0.00% | – |
| Q3 2021 | $13,000 | -55.2% | 1,430 | -55.2% | 0.00% | – |
| Q2 2021 | $29,000 | +190.0% | 3,189 | +435.1% | 0.00% | – |
| Q1 2021 | $10,000 | – | 596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,353,141 | $13,083,464 | 0.76% |
| Integral Health Asset Management, LLC | 760,000 | $4,225,600 | 0.58% |
| Prosight Management, LP | 321,154 | $1,785,616 | 0.57% |
| Parkman Healthcare Partners LLC | 355,957 | $1,979,121 | 0.36% |
| Ikarian Capital, LLC | 514,101 | $2,858,401 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,560,500 | $8,676,380 | 0.04% |
| Polar Capital Holdings Plc | 1,000,000 | $5,560,000 | 0.04% |
| UBS OCONNOR LLC | 262,265 | $1,458,193 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,614 | $626,134 | 0.02% |
| Point72 Asset Management, L.P. | 825,000 | $4,587,000 | 0.01% |